Treatment of rest-activity disorders in dementia and special focus on sundowning

International Journal of Geriatric Psychiatry

Volumn 20, Issue 6, 2005, Pages 507-511

  Staedt, Jürgen ^a   Stoppe, Gabriela ^b  

^a VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; MELATONIN; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

AGING; ALZHEIMER DISEASE; CHRONOBIOLOGY; CIRCADIAN RHYTHM; CLINICAL TRIAL; COGNITION; DEGENERATIVE DISEASE; DELIRIUM; DELUSION; DEMENTIA; DRUG MECHANISM; EDITORIAL; HUMAN; MEMORY; MUSIC THERAPY; PHOTOTHERAPY; REST; SLEEP DISORDER; SUNDOWNING; SYNDROME DELINEATION;

AGED; CHRONOBIOLOGY; COGNITION DISORDERS; DEMENTIA; HUMANS; PSYCHOMOTOR AGITATION; SLEEP DISORDERS;

EID: 21044431624     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.1307     Document Type: Editorial

References (68)

1. Aarsland D, Laake K, Larsen JP, et al. 2002. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 72: 708-712.
2. Ancoli-Israel S, Kripke DF. 1989. Now I lay me down to sleep: the problem of sleep fragmentation in the elderly and demented residents of nursing homes. Bull Clin Neurosci 1154: 127-132.
3. Ancoli-Israel S, Martin JL, Gehrman P, et al. 2003. Effect of light on agitation in institutionalized patients with severe Alzheimer disease. Am J Geriatr Psychiatry 11: 194-203.
4. Asayama K, Yamadera H, Ito T, et al. 2003. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J Nippon Med Sch 70: 334-341.
5. Barinaga M. 1997. How jet-lag hormone does double duty in the brain. Science 277: 480.
6. Basseti C, Aldrich MS, Chervin RD, et al. 1996. Sleep apnea in patients with transient ischemic attack and stroke. Neurology 47: 1167-1173.
7. Belenky MA, Pickard GE. 2001. Subcellular distribution of 5-HT(1B) and 5-HT (7) receptors in the mouse suprachiasmatic nucleus. Comp Neurol 432: 371-388.
8. Black S, Roman GC, Geldmacher DS, et al. 2003. Donepezil 307 Vascular Dementia Study Group. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 34(10): 2323-2330.
9. Bliwise DL. 1994. What is sundowning? J Am Geriatr Soc 42: 1009-1011.
10. Bliwise DL, Hughes M, McMahon PM, et al. 1995. Observed sleep/wakefulness and severity of dementia in an Alzheimer's diesease special care unit. J Gerontol A Biol Sci Med Sci 50: 303-306.
11. Bliwise DL, Adelman CL, et al. 2004. Polysomnographic correlates of spontaneous nocturnal wetness episodes in incontinent geriatric patients. Sleep 27: 153-157.
12. Bullock R. 2004. Cholinesterase inhibitors and vascular dementia: another string to their bow? CNS Drugs 18: 79-92.
13. Burgio LD, Scilley M, Hardin M, Hsu C. 2001 Temporal patterns of disruptive vocalization in elderly nursing home residents. Int J Geriatr Psychiatry 16: 378-386.
14. Burns A, Spiegel R, Quarg P. 2004. Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease. Int J Geriatr Psychiatry 19: 243-249.
15. Cacabelos R, Rodriguez B, Carrera C, et al. 1996. APOE-related frequency of cognitive and noncognitive symptoms in dementia. Methods Find Exp Clin Pharmacol 18: 693-706.
16. Cardinali DP, Brusco LI, Liberczuk C, et al. 2002. The use of melatonin in Alzheimer's disease. Neuroendocrinol Lett 23: 20-23.
17. Coen RF, Swanwick GR, O'Boyle CA, et al. 1997. Behaviour disturbance and other predictors of carer burden Alzheimer's disease. Int J Geriatr Psychiatry 12: 331-336.
18. Erkinjuntti T, Kurz A, Gauthier S, et al. 2002. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 359: 1283-1290.
19. Evans LK. 1987. Sundown syndrome in institutionalized elderly. J Am Geriatr Soc 35: 101-108.
20. Feldman H, Gauthier S, Hecker J, et al. 2001. Donepezil MSAD Study Investigators Group: a 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology 57: 613-620.
21. Feldman H, Gauthier S, Hecker J, et al. 2003. Donepezil MSAD Study Investigators Group: efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. J Am Geriatr Soc 51: 737-744.
22. Foley DJ, Monjan AA, Brown SL, et al. 1995. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 18: 425-432.
23. Gallagher-Thompson D, Brooks JO III, et al. 1992. The relations among caregiver stress, 'sundowning' symptoms, and cognitive decline in Alzheimer's disease. J Am Geriatr Soc 40: 807-810.
24. Gasio PF, Kräuchli K, Cajochen C, et al. 2003. Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly. Experiment Gerontol 38: 207-216.
25. Graessel E. 2000. Warum pflegen Angehörige? Ein Pflegemodell für die häusliche Pflege im höheren Lebensafter. Zschr Gerontopsychol Psychiatr 13: 85-94.
26. Haffmans PM, Sival RC, Lucius SA, et al. 2001. Bright light therapy and melatonin in motor restless behaviour in dementia: a placebo-controlled study. Int J Geriatr Psychiatry 16: 106-110.
27. Jelicic M, Bosma H, Ponds RW, et al. 2002. Subjective sleep problems in later life as predictors of cognitive decline. Report from the Maastricht Ageing Study (MAAS). Int J Geriatr Psychiatry 17: 73-77.
28. Jin X, von Gall C, Pieschl RL, et al. 2003. Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 23: 1054-1060.
29. Kumar AM, Tims F, Cruess DG, et al. 1999. Music therapy increases melatonin levels in patients with Alzheimer's disease. Altern Ther Health Med 5: 49-57.
30. Kurz AF, Erkinjuntti T, Small GW, et al. 2003. Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease. Eur J Neurol 10: 633-640.
31. Lavie P. 1997. Melatonin: role in gating nocturnal rise in sleep propensity. J Biol Rhythms 12: 627-665.
32. Liu C, Weaver DR, Jin X, et al. 1997. Molecular dissection of two distinct actions of melatonin on suprachiasmatic circadian clock. Neuron 19: 91-102.
33. Lyketsos CG, Lindell Veiel L, Baker A, et al. 1999. A randomized, controlled trail of bright light therapy for agitated behaviors in dementia patients residing in long-term care. Int J Geriatr Psychiatry 14: 520-525.
34. Madeira MD, Pereira PA, Silva SM, et al. 2004. Basal forebrain neurons modulate the synthesis and expression of neuropeptides in the rat suprachiasmatic nucleus. Neuroscience 125: 889-901.
35. Malouf R, Birks J. 2004. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev(1): CD004395.
36. Martin J, Marler M, Shochat T, et al. 2000. Circadian rhythms of agitation in institutionalized patients with Alzheimer's disease. Chronobiol Int 17; 405-418.
37. McCurry SM, Gibbons LE, Logsdon RG, et al. 2003. Training caregivers to change the sleep hygiene practices of patients with dementia: the NITE-AD project. J Am Geriatr Soc 51: 1455-1460.
38. McGeer PL, McGeer EG, Suzuki J, et al. 1984. Aging, Alzheimer's disease, and the cholinergic systen of the basal forebrain. Neurology 34: 741-745.
39. McKeith IG, Grace JB, Walker Z, et al. 2000. Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial. Int J Geriatr Psychiatry 15: 387-392.
40. Miller JD. 1993. On the nature of the circadian clock in mammals. Am J Physiol 264: 821-832.
41. Mishima K, Okawa M, Shimizu T, et al. 2001. Diminished melatonin secretion in the elderly caused by insufficient environmental illumination. J Clin Endocrinol Metabol 86: 129-134.
42. Moretti R, Torre P, Antonello RM, et al. 2003. Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients. Am J Alzheimers Dis Other Demen 18(5): 265-272.
43. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study. 2001. Pathological correlates of late-onset dementia in a multicentre, community-based population in Englang and Wales. Lancet 357: 169-175.
44. Nunez A. 1996. Unit activity of rat basal forebrain neurons: relationship to cortical activity. Neuroscience 72: 757-766.
45. Okumoto Y, Koyama E, Matsubara H, et al. 1998. Sleep improvement by light in a demented aged individual. Psychiatry Clin Neurosci 52: 194-196.
46. Pollak CP, Perlick D, Linsner JP, et al. 1990. Sleep problem in the community elderly as predictors of death and nursing home placement. J Commun Hlth 15: 123-135.
47. Pollak CP, Stokes PE. 1997. Circadian rest-activity rhythms in demented and nondemented older community residents and their caregivers. J Am Geriatr Soc 45: 446-452.
48. Reinikainen KJ, Riekkinen PJ, Paljärvi L, et al. 1988. Cholinergic deficit in Alzheimer's disease: a study based on CSF and autopsy data. Neurochem Res 13: 135-146.
49. Riekkinen J Jr, Sirviö J, Riekkinen P. 1990. Relation between EEG delta power and the cortical choline acetyltransferase content. Neurosci Res 8: 12-20.
50. Samuel W, Caligiuri M, Galasko D, et al. 2000. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry 15: 794-802.
51. Satlin A, Volicer L, Ross V, et al. 1992. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. Am J Psychiatry 149: 1028-1032.
52. Serfaty M, Kennell-Webb S, Warner J, et al. 2002. Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry 17: 1120-1127.
53. Shochat T, Martin J, Marler M, et al. 2000. Illumination levels in nursing home patients: effects on sleep and activity rhythms. J Sleep Res 9: 337-373.
54. Staedt J, Stoppe G. 2004. Are sleep and its disorders of interest for psychiatric and psychosomatic medicine? In Advances in Psychosomatic Medicine, Diefenbacher A (ed.), Vol. 26. Karger: Basel; 1-6.
55. Steriade M. 2004. Acetylcholine systems and rhythmic acticities during the waking-sleep cycle. Prog Brain Res 145: 179-196.
56. Stoppe G, Brandt C, Staedt J. 1999. Behavioural problems associated with dementia: the role of newer antipsychiotics. Drugs & Aging 14: 41-54.
57. Tractenberg RE, Singer CM, Cummings JL, et al. 2003. The sleep disorders inventory: an instrument for studies of sleep disturbance in persons with alzheimers disease. J Sleep Res 12: 331-337.
58. Teri L, Logsdon RG, McCurry SM. 2002. Nonpharmacologic treatment of behavioral disturbance in dementia. Med Clin North Am 86: 641-656.
59. Trinh NH, Hoblyn J, Mohanty S, et al. 2003. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. J Am Med Ass 289: 210-216.
60. Van Someren EJW, Hagebeak EEO, Lijzenga C, et al. 1996. Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry 40: 259-270.
61. Van Someren EJ, Kessler A, Mirmiran M, et al. 1997. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 41: 955-963.
62. Volicer L, Harper DG, Manning BC, et al. 2001. Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry 158: 704-711.
63. Wilkinson D, Doody R, Helme R, et al. 2003. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 26;61(4): 479-486.
64. Wenk GL. 1997. The nucleus basalis magnocellularis cholinergic system: one hundred years of progress. Neurobiol Learn Memory 67: 85-95.
65. Werth E, Savaskan E, Knoblauch V, et al. 2002. Decline in long-term circadian rest-activity cycle organization in a patient with dementia. J Geriatr Psychiatry Neurol 15: 55-59.
66. Wu YH, Feenstra MG, Zhou JN, et al. 2003. Molecular changes underlying reduced pineal melatonin levels in Alzheimer's disease: alterations in preclinical und clincal stages. J Clin Endocrinol Metab 88: 5898-5906.
67. Yoon IY, Kripke DF, Elliott JA, et al. 2003. Age-related changes of circadian rhythms and sleep-wake cycles. Am Geriatr Soc 51: 1085-1091.
68. Yuen EJ, Zisselman MH, Louis DZ, et al. 1997. Sedative-hypnotic use by the elderly: effects on hospital length of stay and costs. J Ment Hlth Administr 24: 90-97.